Literature DB >> 9293379

A thermolabile beta 2-macroglycoprotein (TMG) and the antibody against TMG in patients with systemic lupus erythematosus.

S Yoshizawa1, K Nagasawa, Y Yae, Y Niho, K Okochi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9293379     DOI： 10.1016/s0009-8981(97)00078-8

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN： 0009-8981            Impact factor:   3.786


× No keyword cloud information.
  7 in total

Review 1.  Complement activation, regulation, and molecular basis for complement-related diseases.

Authors:  Goran Bajic; Søren E Degn; Steffen Thiel; Gregers R Andersen
Journal:  EMBO J       Date:  2015-10-21       Impact factor: 11.598

2.  Detection of serum thermolabile beta-2 macroglycoprotein (Hakata antigen) by enzyme-linked immunosorbent assay using polysaccharide produced by Aerococcus viridans.

Authors:  M Tsujimura; C Ishida; Y Sagara; T Miyazaki; K Murakami; H Shiraki; K Okochi; Y Maeda
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

3.  Ficolin-3 Deficiency Is Associated with Disease and an Increased Risk of Systemic Lupus Erythematosus.

Authors:  Anne Troldborg; Rudi Steffensen; Marten Trendelenburg; Thomas Hauser; Kasper G Winther; Annette G Hansen; Kristian Stengaard-Pedersen; Anne Voss; Steffen Thiel
Journal:  J Clin Immunol       Date:  2019-05-01       Impact factor: 8.317

Review 4.  The Immunopathology of Complement Proteins and Innate Immunity in Autoimmune Disease.

Authors:  Federica Defendi; Nicole M Thielens; Giovanna Clavarino; Jean-Yves Cesbron; Chantal Dumestre-Pérard
Journal:  Clin Rev Allergy Immunol       Date:  2020-04       Impact factor: 8.667

5.  No strong relationship between mannan binding lectin or plasma ficolins and chemotherapy-related infections.

Authors:  D C Kilpatrick; L A McLintock; E K Allan; M Copland; T Fujita; N E Jordanides; C Koch; M Matsushita; H Shiraki; K Stewart; M Tsujimura; M L Turner; I M Franklin; T L Holyoake
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

6.  L-ficolin in children with recurrent respiratory infections.

Authors:  A P M Atkinson; M Cedzynski; J Szemraj; A St Swierzko; L Bak-Romaniszyn; M Banasik; K Zeman; M Matsushita; M L Turner; D C Kilpatrick
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

7.  Association between the Presence of Autoantibodies Targeting Ficolin-3 and Active Nephritis in Patients with Systemic Lupus Erythematosus.

Authors:  Maëlle Plawecki; Elise Lheritier; Giovanna Clavarino; Noémie Jourde-Chiche; Saber Ouili; Stéphane Paul; Evelyne Gout; Françoise Sarrot-Reynauld; Nathalie Bardin; Pierre-Yves Boëlle; Laurent Chiche; Laurence Bouillet; Nicole M Thielens; Jean-Yves Cesbron; Chantal Dumestre-Pérard
Journal:  PLoS One       Date:  2016-09-15       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.